DK1339723T3 - Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner - Google Patents
Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporinerInfo
- Publication number
- DK1339723T3 DK1339723T3 DK01999226T DK01999226T DK1339723T3 DK 1339723 T3 DK1339723 T3 DK 1339723T3 DK 01999226 T DK01999226 T DK 01999226T DK 01999226 T DK01999226 T DK 01999226T DK 1339723 T3 DK1339723 T3 DK 1339723T3
- Authority
- DK
- Denmark
- Prior art keywords
- cephalosporins
- preparation
- ester derivatives
- derivatives useful
- useful
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/08—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25101800P | 2000-12-04 | 2000-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1339723T3 true DK1339723T3 (da) | 2006-06-12 |
Family
ID=22950131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01999226T DK1339723T3 (da) | 2000-12-04 | 2001-11-19 | Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020099205A1 (da) |
| EP (1) | EP1339723B1 (da) |
| JP (1) | JP2004515503A (da) |
| KR (1) | KR100526380B1 (da) |
| CN (1) | CN1243756C (da) |
| AR (1) | AR035076A1 (da) |
| AT (1) | ATE319719T1 (da) |
| AU (2) | AU2002223929B2 (da) |
| BR (1) | BR0115872A (da) |
| CA (1) | CA2436863C (da) |
| CY (1) | CY1104995T1 (da) |
| CZ (1) | CZ20031526A3 (da) |
| DE (1) | DE60117876T2 (da) |
| DK (1) | DK1339723T3 (da) |
| ES (1) | ES2257471T3 (da) |
| HK (1) | HK1059265A1 (da) |
| HU (1) | HUP0400686A3 (da) |
| IL (1) | IL155701A0 (da) |
| MX (1) | MXPA03004938A (da) |
| PL (1) | PL362078A1 (da) |
| PT (1) | PT1339723E (da) |
| RU (1) | RU2237671C1 (da) |
| WO (1) | WO2002046199A1 (da) |
| ZA (1) | ZA200303498B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1243755C (zh) * | 2000-12-04 | 2006-03-01 | 辉瑞产品公司 | 用于制备头孢菌素的偶合方法和中间体 |
| KR100830754B1 (ko) * | 2004-03-09 | 2008-05-19 | 화이자 프로덕츠 인코포레이티드 | α-요오도-1-아제티딘아세트산 에스테르 및 트라이알킬포스파이트를 이용한 세팔로스포린 중간체의 제조방법 |
| US20070208172A1 (en) * | 2004-03-09 | 2007-09-06 | Pfizer Inc. | Process for Preparing Cephalosporin Intermediates Using Alpha-Iodo-1-Azetidineacetic Acid Esters and Trialkylphosphites |
| EP1951723B1 (en) | 2005-10-20 | 2017-08-30 | Postech Academy-Industry Foundation | The application using non-covalent bond between a cucurbituril derivative and a ligand |
| CN102372738B (zh) * | 2010-08-14 | 2017-11-10 | 武汉工程大学 | Lj反应在制备维蒂希试剂和草铵膦中的应用 |
| CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
| GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
| CN111892612A (zh) * | 2020-07-31 | 2020-11-06 | 重庆医药高等专科学校 | 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001997A (en) * | 1990-07-24 | 1999-12-14 | Bateson; John Hargreaves | Cephalosporins and homologues, preparations and pharmaceutical compositions |
| MY106399A (en) * | 1990-07-24 | 1995-05-30 | Pfizer | Cephalosporins and homologeus, preparation and pharmaceutical composition |
| US6020329A (en) * | 1990-07-24 | 2000-02-01 | Pzifer Inc. | Cephaloporins and homologues, preparations and pharmaceutical compositions |
| GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
| GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
| GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
-
2001
- 2001-11-19 DE DE60117876T patent/DE60117876T2/de not_active Expired - Fee Related
- 2001-11-19 RU RU2003116520/04A patent/RU2237671C1/ru not_active IP Right Cessation
- 2001-11-19 PL PL01362078A patent/PL362078A1/xx unknown
- 2001-11-19 CA CA002436863A patent/CA2436863C/en not_active Expired - Fee Related
- 2001-11-19 CN CNB018195792A patent/CN1243756C/zh not_active Expired - Fee Related
- 2001-11-19 PT PT01999226T patent/PT1339723E/pt unknown
- 2001-11-19 BR BR0115872-4A patent/BR0115872A/pt not_active IP Right Cessation
- 2001-11-19 KR KR10-2003-7007397A patent/KR100526380B1/ko not_active IP Right Cessation
- 2001-11-19 IL IL15570101A patent/IL155701A0/xx unknown
- 2001-11-19 AU AU2002223929A patent/AU2002223929B2/en not_active Ceased
- 2001-11-19 AU AU2392902A patent/AU2392902A/xx active Pending
- 2001-11-19 MX MXPA03004938A patent/MXPA03004938A/es active IP Right Grant
- 2001-11-19 HU HU0400686A patent/HUP0400686A3/hu unknown
- 2001-11-19 AT AT01999226T patent/ATE319719T1/de not_active IP Right Cessation
- 2001-11-19 CZ CZ20031526A patent/CZ20031526A3/cs unknown
- 2001-11-19 WO PCT/IB2001/002181 patent/WO2002046199A1/en active IP Right Grant
- 2001-11-19 JP JP2002547936A patent/JP2004515503A/ja active Pending
- 2001-11-19 DK DK01999226T patent/DK1339723T3/da active
- 2001-11-19 ES ES01999226T patent/ES2257471T3/es not_active Expired - Lifetime
- 2001-11-19 EP EP01999226A patent/EP1339723B1/en not_active Expired - Lifetime
- 2001-12-03 AR ARP010105608A patent/AR035076A1/es active IP Right Grant
- 2001-12-04 US US10/006,579 patent/US20020099205A1/en not_active Abandoned
-
2003
- 2003-05-07 ZA ZA200303498A patent/ZA200303498B/en unknown
-
2004
- 2004-02-17 US US10/781,158 patent/US20040267008A1/en not_active Abandoned
- 2004-03-24 HK HK04102181A patent/HK1059265A1/xx not_active IP Right Cessation
-
2006
- 2006-03-15 CY CY20061100361T patent/CY1104995T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002046199A1 (en) | 2002-06-13 |
| CZ20031526A3 (en) | 2004-04-14 |
| IL155701A0 (en) | 2003-11-23 |
| HUP0400686A3 (en) | 2010-03-29 |
| DE60117876T2 (de) | 2006-08-31 |
| CA2436863A1 (en) | 2002-06-13 |
| KR20030070044A (ko) | 2003-08-27 |
| HUP0400686A2 (hu) | 2004-06-28 |
| US20040267008A1 (en) | 2004-12-30 |
| RU2237671C1 (ru) | 2004-10-10 |
| AU2002223929B2 (en) | 2007-08-23 |
| AU2392902A (en) | 2002-06-18 |
| ATE319719T1 (de) | 2006-03-15 |
| AR035076A1 (es) | 2004-04-14 |
| EP1339723A1 (en) | 2003-09-03 |
| PL362078A1 (en) | 2004-10-18 |
| WO2002046199A8 (en) | 2003-06-12 |
| CA2436863C (en) | 2007-05-22 |
| US20020099205A1 (en) | 2002-07-25 |
| CY1104995T1 (el) | 2009-11-04 |
| HK1059265A1 (en) | 2004-06-25 |
| PT1339723E (pt) | 2006-06-30 |
| ZA200303498B (en) | 2004-05-07 |
| KR100526380B1 (ko) | 2005-11-08 |
| EP1339723B1 (en) | 2006-03-08 |
| JP2004515503A (ja) | 2004-05-27 |
| CN1478094A (zh) | 2004-02-25 |
| DE60117876D1 (de) | 2006-05-04 |
| CN1243756C (zh) | 2006-03-01 |
| MXPA03004938A (es) | 2003-09-10 |
| ES2257471T3 (es) | 2006-08-01 |
| BR0115872A (pt) | 2003-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1657310T3 (da) | Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf | |
| NO20030844D0 (no) | Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav | |
| DK1292561T3 (da) | Fremgangsmåde til fremstillingen af cyclopropylcarboxylsyreestere og -derivater | |
| NO20054715L (no) | Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser | |
| CY2007029I2 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| NO20021382L (no) | Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| CY2009001I1 (el) | Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης | |
| NO20015542L (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| DK1328538T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener | |
| NO20003555L (no) | Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer | |
| DK1339723T3 (da) | Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner | |
| DK1294694T3 (da) | Fremgangsmåde til fremstilling af quinolinderivater | |
| NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| DK0899262T3 (da) | Fremgangsmåde til fremstilling af heteroarylcarboxylamider og -estere | |
| DK1254159T3 (da) | Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider | |
| DK1165483T3 (da) | Fremgangsmåde til fremstilling af carbonylfluorid | |
| NO20032297L (no) | Fremgangsmåte for fremstilling av distamycinderivater | |
| NO20030587L (no) | Fremgangsmåte til fremstilling av diskodermolid og analoger derav | |
| NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol | |
| DK0930297T3 (da) | Fremgangsmåde til fremstilling af naphtyridoner og mellemprodukter | |
| NO20020327D0 (no) | Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol | |
| DK1147074T3 (da) | Fremgangsmåde til fremstilling af nitroxymethylphenylestere af aspirinderivater | |
| DK1347958T3 (da) | Fremgangsmåde til fremstilling af distamycinderivter |